Sign inJoin waitlistJoin the waitlist

MC

Matthew Cooney

Physician · UHMG INC

Credentials: · ·

History

UHMG INC
Present

Hematology and Medical Oncology
2001–2004
Internal Medicine
1998–2001
Case Western Reserve University School of Medicine
1994–1998

Research

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
New England Journal of Medicine · 2015 · 2,355 citations
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Journal of Clinical Oncology · 2018 · 871 citations
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
The Lancet · 2016 · 464 citations

Scot Remick
18 papers
Afshin Dowlati
13 papers
Robert Dreicer
13 papers
Jorge Garcia
10 papers · 1 as a fellow
Joseph Bokar
8 papers
NV
Nicholas Vogelzang
7 papers
Joanna Brell
6 papers
JG
Joseph Gibbons
6 papers
Smitha Krishnamurthi
6 papers
Jose Ortiz
5 papers
BO
Beth Overmoyer
4 papers
Brian Rini
4 papers

Clinical trials

Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy
Principal investigator · Completed · Phase 1, Phase 2
Case Comprehensive Cancer Center
2009–2014
Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Principal investigator · Completed · Phase 2
Case Comprehensive Cancer Center
2006–2010
CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to Treatment
Study chair · Completed · Phase 1
Case Comprehensive Cancer Center
2007–2012
Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors
Study chair · Completed · Phase 1
Case Comprehensive Cancer Center
2005–2008